Clinical Transplantation

Papers
(The TQCC of Clinical Transplantation is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Early effects of first‐line treatment with anti‐interleukin‐6 receptor antibody tocilizumab for chronic active antibody‐mediated rejection in kidney transplantation49
Clinical “real‐world” experience with letermovir for prevention of cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients43
Outcomes of COVID‐19 in hospitalized solid organ transplant recipients compared to a matched cohort of non‐transplant patients at a national healthcare system in the United States41
SARS‐COV‐2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications38
Pediatric transplantation in Europe during the COVID‐19 pandemic: Early impact on activity and healthcare35
Pig kidney xenotransplantation: Progress toward clinical trials35
Bamlanivimab for treatment of COVID‐19 in solid organ transplant recipients: Early single‐center experience31
Incidence, risk factors, treatment, and consequences of antibody‐mediated kidney transplant rejection: A systematic review30
Convalescent plasma therapy: Helpful treatment of COVID‐19 in a kidney transplant recipient presenting with severe clinical manifestations and complex complications30
Hypothermic machine perfusion is superior to static cold storage in deceased donor kidney transplantation: A meta‐analysis30
Organ donation and transplant: The Islamic perspective29
Direct bridging to cardiac transplantation with the surgically implanted Impella 5.0 device28
Financial impact of delayed graft function in kidney transplantation28
Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS‐CoV‐2 vaccine27
Cardiac allograft vasculopathy: Insights on pathogenesis and therapy27
Excess mortality in solid organ transplant recipients hospitalized with COVID‐19: A large‐scale comparison of SOT recipients hospitalized with or without COVID‐1926
Does liver biopsy accurately measure fibrosis in Fontan‐associated liver disease? A comparison of liver biopsy pre–combined heart and liver transplant and liver explant post‐transplant25
Early United States experience with liver donation after circulatory determination of death using thoraco‐abdominal normothermic regional perfusion: A multi‐institutional observational study24
State‐of‐the‐art machine learning algorithms for the prediction of outcomes after contemporary heart transplantation: Results from the UNOS database24
Viability testing of discarded livers with normothermic machine perfusion: Alleviating the organ shortage outweighs the cost23
Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donors23
A short overview on mycophenolic acid pharmacology and pharmacokinetics23
Evolving Impact of COVID‐19 on Transplant Center Practices and Policies in the United States23
Development of the living donation and kidney transplantation information made easy (KidneyTIME) educational animations23
Intraoperative transfusion management, antifibrinolytic therapy, coagulation monitoring and the impact on short‐term outcomes after liver transplantation—A systematic review of the literature and expe23
Attenuated early inflammatory response in solid organ recipients with COVID‐1923
Treatment with convalescent plasma in solid organ transplant recipients with COVID‐19: Experience at large transplant center in New York City23
Enhanced recovery after surgery programs improve short‐term outcomes after liver transplantation–A systematic review and meta‐analysis22
Impact of heart transplant allocation change on competing waitlist outcomes among listing strategies22
Transplant outcomes using kidneys from high KDPI acute kidney injury donors21
Protocolized exercise improves frailty parameters and lower extremity impairment: A promising prehabilitation strategy for kidney transplant candidates20
Global experience and perspective on anonymous nondirected live donation in living donor liver transplantation19
Does machine perfusion improve immediate and short‐term outcomes by enhancing graft function and recipient recovery after liver transplantation? A systematic review of the literature, meta‐analysis an19
To kidney or not to kidney: Applying lessons learned from the simultaneous liver‐kidney transplant policy to simultaneous heart‐kidney transplantation19
Tocilizumab use in Kidney Transplant Patients with COVID‐1919
The shared epitope phenomenon—A potential impediment to virtual crossmatch accuracy18
Engraftment syndrome following hematopoietic stem cell transplant: A review of the literature18
Pre‐transplant short physical performance battery: Response to pre‐habilitation and relationship to pre‐ and early post–lung‐transplant outcomes18
Using race to estimate glomerular filtration and its impact in kidney transplantation17
Evolving utilization of donation after circulatory death livers in liver transplantation: The day of DCD has come17
Telehealth in outpatient management of kidney transplant recipients during COVID‐19 pandemic in New York17
The influence of ischemia and reperfusion time on outcome in heart transplantation17
Prognostic value of the donor‐derived cell‐free DNA assay in acute renal rejection therapy: A prospective cohort study17
Removal of the Black race coefficient from the estimated glomerular filtration equation improves transplant eligibility for Black patients at a single center16
Extracorporeal photopheresis and its role in heart transplant rejection: prophylaxis and treatment16
COVID‐19 in hospitalized liver transplant recipients: An early systematic review and meta‐analysis16
Impact of pre‐transplant carbapenem‐resistant Enterobacterales colonization and/or infection on solid organ transplant outcomes16
Transversus abdominis plane (TAP) block for laparoscopic live donor nephrectomy: Continuous catheter infusion provides no additional analgesic benefit over single‐injection ropivacaine15
Abdominal wall complications after kidney transplantation: A clinical review15
Comparable survival outcome between transplantation from haploidentical donor and matched related donor or unrelated donor for severe aplastic anemia patients aged 40 years and older: A retrospective 15
Gut microbiota profiles and fecal beta‐glucuronidase activity in kidney transplant recipients with and without post‐transplant diarrhea15
Belatacept, kidney transplantation and COVID‐19: Successful management of the first reported case within the United Kingdom15
Utilization of direct‐acting oral anticoagulation in solid organ transplant patients: A national survey of institutional practices15
Describing barriers and facilitators for medication adherence and self‐management among kidney transplant recipients using the information‐motivation‐behavioral skills model14
Induction immunosuppression strategies and long‐term outcomes after heart transplantation14
Influence of patient characteristics and immunosuppressant management on mortality in kidney transplant recipients hospitalized with coronavirus disease 2019 (COVID‐19)14
Transplantation of viral‐positive hepatitis C‐positive kidneys into uninfected recipients offers an opportunity to increase organ access14
Outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis14
Donor‐derived cell‐free DNA is associated with cardiac allograft vasculopathy14
Impact of a multidisciplinary multimodal opioid minimization initiative in kidney transplant recipients14
The type of SARS‐CoV‐2 vaccine influences serological response in kidney transplant recipients14
Targeting the NLRP3 inflammasome to reduce warm ischemic injury in donation after circulatory death heart14
Clinical judgment versus lung allocation score in predicting lung transplant waitlist mortality13
Renal transplantation during the SARS‐CoV‐2 pandemic in the UK: Experience from a large‐volume center13
Pediatric lung transplantation as standard of care13
Cell‐free microRNAs as early predictors of graft viability during ex vivo normothermic machine perfusion of human donor livers13
Gender differences in heart transplantation: Twenty‐five year trends in the nationwide Spanish heart transplant registry13
A proposed strategy for management of immunosuppression in heart transplant patients with COVID‐1913
Wait expectations: The impact of delisting as an outcome from the kidney transplant waitlist13
Genome‐wide association study for time to failure of kidney transplants from African American deceased donors13
The impact of the SARS‐CoV‐2 pandemic and COVID‐19 on lung transplantation in the UK: Lessons learned from the first wave13
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De‐novo heart transplant recipients: Design of the randomized controlled EVOLVD trial13
Operational challenges in the COVID‐19 era: Asymptomatic infections and vaccination timing13
Sex differences in eligibility for advanced heart failure therapies13
Heart transplant recipients with confirmed 2019 novel coronavirus infection: The Detroit experience13
What is the optimal antimicrobial prophylaxis to prevent postoperative infectious complications after liver transplantation? A systematic review of the literature and expert panel recommendations12
Disparities in DCD organ procurement policy from a national OPO survey: A call for standardization12
Mobile health technology to improve emergent frailty after lung transplantation12
The incidence, clinical outcome, and protective factors of mixed chimerism following hematopoietic stem cell transplantation for severe aplastic anemia12
Impact of UNOS allocation policy changes on utilization and outcomes of patients bridged to heart transplant with intra‐aortic balloon pump12
A single‐center long‐term experience with marginal donor utilization for heart transplantation12
Lung transplantation for the treatment of irreversible acute respiratory distress syndrome12
A Step toward Standardization: Results of two National Surveys of Best Practices in Donation after Circulatory Death Liver Recovery and Recommendations from The American Society of Transplant Surgeons12
Exploring the motives of Israeli Jews who were living kidney donors to strangers12
Does modification of portal pressure and flow enhance recovery of the recipient after living donor liver transplantation? A systematic review of literature and expert panel recommendations12
Association of race and gender with primary caregiver relationships and eligibility for advanced heart failure therapies12
Impact of the United Network for organ sharing 2018 donor heart allocation system on transplant morbidity and mortality12
Normothermic with or without hypothermic oxygenated perfusion for DCD before liver transplantation: European multicentric experience12
Prevalence and characterization of frailty, depression, and cognitive impairment in patients listed for heart transplantation: Results of the FELICITAR prospective registry12
Immunosuppression practices during the COVID‐19 pandemic: A multinational survey study of transplant programs12
Immune response to third SARS‐CoV‐2 vaccination in seronegative kidney transplant recipients: Possible improvement by mycophenolate mofetil reduction12
Sodium‐glucose cotransporter 2 inhibitors for treatment of diabetes mellitus after kidney transplantation11
SARS‐CoV‐2 infection increases tacrolimus concentrations in solid‐organ transplant recipients11
Comparing outcomes for infiltrative and restrictive cardiomyopathies under the new heart transplant allocation system11
Kidney allograft rejection: Diagnosis and treatment practices in USA‐ A UNOS survey11
Donor acute kidney injury and its effect on 1‐year post‐transplant kidney allograft fibrosis11
Long‐term results of a randomized study comparing parathyroidectomy with cinacalcet for treating tertiary hyperparathyroidism11
Model for early allograft function is predictive of early graft loss in donation after circulatory death liver transplantation11
Donor thyroid hormone therapy is associated with an increased risk of graft dysfunction after heart transplantation11
CD4+ T cell lymphopenia predicts mortality from Pneumocystis pneumonia in kidney transplant patients11
A retrospective multi‐center experience of renal transplants from India during COVID‐19 pandemic11
eHealth literacy and web‐based patient portal usage among kidney and liver transplant recipients11
Hyperammonemia syndrome associated with Ureaplasma spp. Infections in immunocompromised patients and transplant recipients: A systematic review and meta‐analysis11
Kidney transplantation using lymphocyte depleting induction and standard maintenance immunosuppression at the height of the SARS‐CoV‐2 pandemic in New York City: A single‐center experience11
Histopathologic findings on indication renal allograft biopsies after recovery from acute COVID‐1910
Exercise interventions in solid organ transplant candidates: A systematic review10
National survey of physicians’ perspectives on pharmacogenetic testing in solid organ transplantation10
The changing landscape of pediatric lung transplantation10
Magnetic resonance imaging‐derived proton density fat fraction (MRI‐PDFF) is a viable alternative to liver biopsy for steatosis quantification in living liver donor transplantation10
Polygenic risk score of non‐melanoma skin cancer predicts post‐transplant skin cancer across multiple organ types10
Early persistent hyperparathyroidism post‐renal transplantation as a predictor of worse graft function and mortality after transplantation10
Early changes in IL‐21, IL‐22, CCL2, and CCL4 serum cytokines after outpatient autologous transplantation for multiple sclerosis: A proof of concept study10
Development and preliminary evaluation of an animation (simplifyKDPI) to improve kidney transplant candidate understanding of the Kidney Donor Profile Index10
Perioperative fluid management and outcomes in adult deceased donor liver transplantation – A systematic review of the literature and expert panel recommendations10
Care of international living kidney donor candidates in the United States: A survey of contemporary experience, practice, and challenges10
COVID‐19 in heart transplant recipients during February–August 2020: A systematic review10
Hematopoietic cell transplant outcomes after myeloablative conditioning with fludarabine, busulfan, low‐dose total body irradiation, and rabbit antithymocyte globulin10
Management of BK viremia is associated with a lower risk of subsequent cytomegalovirus infection in kidney transplant recipients10
Hemophagocytic lymphohistiocytosis occurring after liver transplantation: A case series and review of the literature10
Impact of donor smoking history on post heart transplant outcomes: A propensity‐matched analysis of ISHLT registry10
Left‐digit bias and deceased donor kidney utilization10
Predicting harmful alcohol relapse after liver transplant: The HALT score10
Acute kidney injury post‐heart transplant: An analysis of peri‐operative risk factors10
Quick preparation of ABO‐incompatible living donor liver transplantation for acute liver failure9
What is the optimal anesthetic monitoring regarding immediate and short‐term outcomes after liver transplantation?—A systematic review of the literature and expert panel recommendations9
Incidence and risk factors of primary non‐function after liver transplantation using grafts from uncontrolled donors after circulatory death9
Post‐transplant survival in adult congenital heart disease patients as compared to dilated and ischemic cardiomyopathy patients; an analysis of the thoracic ISHLT registry9
Letermovir treatment for CMV infection in kidney and pancreas transplantation: A valuable option for complicated cases9
Longitudinal variance of Donor‐Derived Cell‐Free DNA (dd‐cfDNA) in Stable Kidney Transplant (KTx) patients are influenced by donor/recipient variables9
The COVID‐19 pandemic: A community approach9
Management and tolerability of glecaprevir‐pibrentasvir pharmacotherapy in hepatitis C viremic heart and lung transplant recipients9
Efficacy and safety of febuxostat for treatment of asymptomatic hyperuricemia among kidney transplant patients: A meta‐analysis of observational studies9
Risk of COVID‐19 in young kidney transplant recipients. Results from a single‐center observational study9
Size matching in heart transplantation: Is predicted heart mass the optimal method in a United Kingdom cohort?9
Availability of PEth testing is associated with reduced eligibility for liver transplant among patients with alcohol‐related liver disease9
Associations of perceived information adequacy and knowledge with pursuit of live donor kidney transplants and living donor inquiries among African American transplant candidates9
Nitazoxanide treatment for norovirus infection in solid organ transplant recipients9
Anesthetic management of lung transplantation: Results from a multicenter, cross‐sectional survey by the society for advancement of transplant anesthesia9
Outcomes of hepatitis C virus nucleic acid testing positive donors in aviremic recipients with delayed direct‐acting antiviral initiation9
Infectious complications in allogeneic hematopoietic cell transplant recipients: Review of transplant‐related risk factors and current state of prophylaxis9
ProtekDuo as a bridge to lung transplant and heart‐lung transplant9
Anti‐Hla donor‐specific antibody monitoring in pancreas transplantation: Role of protocol biopsies9
Variations in deceased donor kidney procurement biopsy practice patterns: A survey of U.S. organ procurement organizations9
The role of early extubation on short‐term outcomes after liver transplantation – A systematic review, meta‐analysis and expert recommendations8
Transplantation of liver from hepatitis C–infected donors to hepatitis C RNA–negative recipients: Histological and virologic outcome8
Ethical considerations regarding COVID‐19 vaccination for transplant candidates and recipients8
Molecular assessment of antibody‐mediated rejection in human pancreas allograft biopsies8
Evaluation and care of international living kidney donor candidates: Strategies for addressing common considerations and challenges8
Meta‐analysis and systematic review: Prevalence, graft failure, mortality, and post‐operative thrombosis in liver transplant recipients with pre‐operative portal vein thrombosis8
Decreased frequency of transplantation and lower post‐transplant survival free of re‐transplantation in LVAD patients with the new heart transplant allocation system8
Takotsubo syndrome after liver transplantation: An association with intraoperatively administered epinephrine and fentanyl8
Impact of induction therapy on outcomes after heart transplantation8
Acute and chronic kidney disease after pediatric liver transplantation: An underestimated problem8
Outcomes of kidney donors with pre‐ and post‐donation kidney stones8
Survival and renal function after liver transplantation alone in patients meeting the new United Network for Organ Sharing simultaneous liver‐kidney criteria8
Implementation of a mobile team to provide normothermic regional perfusion in controlled donation after circulatory death: Pilot study and first results8
Strict selection criteria in uncontrolled donation after circulatory death provide excellent long‐term kidney graft survival8
Adult liver transplant anesthesiology practice patterns and resource utilization in the United States: Survey results from the society for the advancement of transplant anesthesia8
Public education materials about Vascular Composite Allotransplantation and donation in the United States: Current scope and limitations8
Long‐term outcomes in kidney transplant recipients with end‐stage kidney disease due to anti‐glomerular basement membrane disease8
Impact of diabetes mellitus on clinical outcomes after heart transplantation8
Impact of the duration of normothermic regional perfusion on the results of liver transplant from controlled circulatory death donors: A retrospective, multicentric study8
Primary biliary cholangitis has the highest waitlist mortality in patients with cirrhosis and acute on chronic liver failure awaiting liver transplant8
Blood transfusion of the donor is associated with stage 3 primary graft dysfunction after lung transplantation8
Pancreas transplantation would be easy if the recipients were not diabetic: A practical guide to post‐operative management of diabetic complications in pancreas transplant recipients8
Lung allocation for transplant: The European perspective8
Physician and patient acceptance of policies to reduce kidney discard8
Clinical outcome of kidney transplantation after bariatric surgery: A single‐center, retrospective cohort study8
Levels of donor‐derived cell‐free DNA and chemokines in BK polyomavirus‐associated nephropathy8
Incidence, risk factors, and clinical outcomes associated with Epstein‐Barr virus‐DNAemia and Epstein‐Barr virus‐associated disease in patients after haploidentical allogeneic stem cell transplantatio7
Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients7
Impact of warm ischemia time on outcomes for kidneys donated after cardiac death Post‐KAS7
A prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation7
Which preoperative assessment modalities best identify patients who are suitable for enhanced recovery after liver transplantation? A systematic review of the literature and expert panel recommendatio7
Gastric peroral endoscopic myotomy (GPOEM) for severe gastroparesis after lung transplantation: A promising minimally invasive option7
Association between increased‐risk donor social behaviors and recipient outcomes after heart transplantation7
ABO‐incompatible living kidney transplantation7
Optimal management of perioperative analgesia regarding immediate and short‐term outcomes after liver transplantation – A systematic review, meta‐analysis and expert panel recommendations7
Geographic disparities in heart transplantation persist under the new allocation policy7
Variation in adult living donor liver transplantation in the United States: Identifying opportunities for increased utilization7
Podocyte density is reduced in kidney allografts with high‐risk APOL1 genotypes at transplantation7
Evaluating resilience as a predictor of outcomes in lung transplant candidates7
Impact of body mass index and recipient age on baseline donor‐derived cell free DNA (dd‐cfDNA) in kidney transplant recipients7
Predictive score for immediate extubation after liver transplantation7
The impact of marijuana use on liver transplant recipients: A 900 patient single center experience7
Outcomes among CMV‐mismatched and highly sensitized kidney transplants recipients who develop neutropenia7
Temporal trends and current use of de novo belatacept in kidney transplant recipients in the United States7
Liver transplantation for combined hepatocellular‐cholangiocarcinoma: Outcomes and prognostic factors for mortality. A multicenter analysis7
Avoiding surveillance biopsy: Use of a noninvasive biomarker assay in a real‐life scenario7
Racial disparities in living donor kidney transplantation in the United States7
Intravascular ultrasound–guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipients7
Six‐month risk of Pneumocystis pneumonia following acute cellular rejection: A case‐control study in solid organ transplant recipients7
Cognitive impairment burden in older and younger adults across the kidney transplant care continuum7
Routine comprehensive Aspergillus screening of bronchoalveolar lavage samples in lung transplant recipients7
What's the score? A comparison of deceased donor kidney scoring systems and correlation with graft outcome7
Optimal anesthetic conduct regarding immediate and short‐term outcomes after liver transplantation – Systematic review of the literature and expert panel recommendations7
Alternatives to immediate release tacrolimus in solid organ transplant recipients: When the gold standard is in short supply7
Volumetrics and fit assessments for donor to recipient size matching in pediatric heart transplantation: Is it time for a new paradigm?7
Randomized trial of 3 maintenance regimens (TAC/SRL vs. TAC/MMF vs. CSA/SRL) with low‐dose corticosteroids in primary kidney transplantation: 18‐year results7
Intermediate‐term outcomes of heart transplantation for cardiac amyloidosis in the current era7
Impact of COVID‐19 pandemic on the size of US transplant waiting lists7
An evaluation of the safety and preliminary efficacy of peri‐ and post‐operative treprostinil in preventing ischemia and reperfusion injury in adult orthotopic liver transplant recipients7
Treatment of borderline infiltrates with minimal inflammation in kidney transplant recipients has no effect on allograft or patient outcomes7
The Molecular Microscope (MMDXR) interpretation of thoracic and abdominal allograft biopsies: Putting things in perspective for the clinician7
Performance of echocardiography for detection of portopulmonary hypertension among liver transplant candidates: Meta‐analysis7
Sex and gender disparity in kidney transplantation: Historical and future perspectives7
Plasma mycophenolic acid concentration and the clinical outcome after lung transplantation7
A comparison of cardiopulmonary bypass versus extracorporeal membrane oxygenation: Does intraoperative circulatory support strategy affect outcomes in pediatric lung transplantation?7
Adoption of a novel smart mobile‐health application technology to track chronic immunosuppression adherence in solid organ transplantation: Results of a prospective, observational, multicentre, pilot 7
Lung transplantation outcomes after crossing low‐level donor specific antibodies without planned augmented immunosuppression7
The role of graft to recipient weight ratio on enhanced recovery of the recipient after living donor liver transplantation – A systematic review of the literature and expert panel recommendations7
Increased frequency of heart transplantation, shortened waitlist time and preserved post‐transplant survival in adults with congenital heart disease, on the new heart transplant allocation system7
Controlling Nutritional Status score does not predict patients' overall survival or hepatocellular carcinoma recurrence after deceased donor liver transplantation7
The impact of depression on heart transplant outcomes: A retrospective single‐center cohort study7
Donor management using a specialized donor care facility is associated with higher organ utilization from drug overdose donors7
Conversion to belatacept within 1‐year of renal transplantation in a diverse cohort including patients with donor‐specific antibodies7
Sodium zirconium cyclosilicate use in solid organ transplant recipients and its effect on potassium and immunosuppression7
Textbook surgical outcome in lung transplantation: Analysis of a US national registry7
Transplantation of kidneys after normothermic perfusion: A single center experience7
Long‐term outcomes of Roux‐en‐Y gastric bypass or sleeve gastrectomy in patients with cirrhosis; before, during or after liver transplantation: A single center's experience7
Less bleeding associated with apixaban versus other direct acting oral anticoagulation in solid organ transplant recipients6
Better outcome of COVID‐19 positive kidney transplant recipients during the unremitting stage with optimized anticoagulation and immunosuppression6
Effectiveness and safety of glucagon‐like peptide‐1 receptor agonist in a cohort of kidney transplant recipients6
Use of Continuous Glucose Monitoring for evaluation of hypoglycemia pre‐ and post‐operatively for patients undergoing Total Pancreatectomy with Autologous Islet Cell Transplant6
Immune responses to hepatitis B vaccination after hematopoietic stem cell transplantation in pediatric and young adult patients6
Video education to facilitate patient outreach about living kidney donation: A proof of concept6
Successful outcomes with transplanting kidneys from deceased donors with acute kidney injuryon temporary renal replacement therapy6
Post‐transplant lymphoproliferative disorder with cutaneous involvement: A series of four cases6
Role of a cardio‐renal multi‐disciplinary team meeting in managing cardiovascular risk in patients on kidney transplant waitlists6
Induction immunosuppression and the risk of incident malignancies among older and younger kidney transplant recipients: A prospective cohort study6
A call to action: Feasible strategies to reduce the discard of transplantable kidneys in the United States6
Risk factors for portal vein stenosis in pediatric liver transplantation6
Can direct oral anticoagulants be used in kidney transplant recipients?6
Utilizing multimodal analgesia to evaluate postoperative analgesic requirements in kidney transplant recipients6
Predictive value of chart‐based frailty evaluation for lung transplant candidates6
COVID‐19 test result reporting for deceased donors: Emergent policies, logistical challenges, and future directions6
Combination of pancreas volume and HbA1c level predicts islet yield in patients undergoing total pancreatectomy and islet autotransplantation6
Race does not predict pancreas graft failure after pancreas transplantation in the modern era6
The role of preoperative optimization of the nutritional status on the improvement of short‐term outcomes after liver transplantation? A review of the literature and expert panel recommendations6
Association of Karnofsky Performance Status with waitlist mortality among older and younger adults awaiting kidney transplantation6
When is it safe to perform abdominal transplantation in patients with prior SARS‐CoV‐2 infection: A case series6
Improved surgical outcomes following simultaneous pancreas‐kidney transplantation in the contemporary era6
Autoantibodies to LG3 are associated with poor long‐term survival after liver retransplantation6
Marijuana use among adult liver transplant candidates and recipients6
“Early” and “Late” Hospital readmissions in the first year after kidney transplant at a single center6
The efficacy of interleukin‐1 antagonist
drugs in combination with colchicine in patients with FMF‐AA with colchicine resistance after kidney transplantation: A study with histopathologic evidence6
COVID‐19 in heart transplant recipients—A seroprevalence survey6
Multimodal opioid‐sparing pain management after lung transplantation and the impact of liposomal bupivacaine intercostal nerve block6
Incidence, risk factors, and long‐term outcomes associated with antibody‐mediated rejection — The long‐term Deterioration of Kidney Allograft Function (DeKAF) prospective cohort study6
Tacrolimus time‐in‐therapeutic range is associated with freedom from acute rejection and graft failure following intestinal transplantation6
0.052978992462158